Evidence for Three Subgroups of Female FMR1 Premutation Carriers Defined by Distinct Neuropsychiatric Features: A Pilot Study.
Schmitt, LM; Dominick, KC; Liu, R; Pedapati, EV; Ethridge, LE; Smith, E; Sweeney, JA; Erickson, CA.
Frontiers in Integrative Neuroscience.
2022;
15.
Using head-mounted eye tracking to examine visual and manual exploration during naturalistic toy play in children with and without autism spectrum disorder.
Yurkovic, JR; Lisandrelli, G; Shaffer, RC; Dominick, KC; Pedapati, EV; Erickson, CA; Kennedy, DP; Yu, C.
Scientific Reports.
2021;
11.
Decades of Progress in the Psychopharmacology of Autism Spectrum Disorder.
Henneberry, E; Lamy, M; Dominick, KC; Erickson, CA.
Journal of Autism and Developmental Disorders.
2021;
51:4370-4394.
Psychotropic Drug Treatment Patterns in Persons with Fragile X Syndrome.
Dominick, KC; Andrews, HF; Kaufmann, WE; Berry-Kravis, E; Erickson, CA.
Journal of Child and Adolescent Psychopharmacology.
2021;
31:659-669.
Gaboxadol in Fragile X Syndrome: A 12-Week Randomized, Double-Blind, Parallel-Group, Phase 2a Study.
Budimirovic, DB; Dominick, KC; Gabis, LV; Adams, M; Adera, M; Huang, L; Ventola, P; Tartaglia, NR; Berry-Kravis, E.
Frontiers in Pharmacology.
2021;
12.
CLINICAL UTILITY OF OPTIMIZED FRAGILE X PROTEIN ANALYSIS.
Schmitt, L; Pedapati, E; Dominick, K; Erickson, C.
Journal of the American Academy of Child and Adolescent Psychiatry.
2021;
60.
6.19 Outcomes of Specialized Psychiatric Inpatient Crisis Intervention for Children and Adolescents With Autism Spectrum Disorder and Other Neurodevelopmental Disorders.
Blank, E; Dominick, K; Shaffer, R; Erickson, C; Lamy, M.
Journal of the American Academy of Child and Adolescent Psychiatry.
2021;
60.
Letter to the Editor: Chlorpromazine-Induced Skin Pigmentation in a Pediatric Patient.
Harris, K; Lamy, M; Sorter, M; Frye, C; Terhune, L; Erickson, CA; Ruschman, G; Dominick, KC.
Journal of Child and Adolescent Psychopharmacology.
2021;
31:516-517.
Sex differences in resting EEG power in Fragile X Syndrome.
Smith, EG; Pedapati, EV; Liu, R; Schmitt, LM; Dominick, KC; Shaffer, RC; Sweeney, JA; Erickson, CA.
Journal of Psychiatric Research.
2021;
138:89-95.
Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder-Initial Results of a Randomized, Controlled, Crossover, Pilot Study.
Wink, LK; Reisinger, DL; Horn, P; Shaffer, RC; O'Brien, K; Schmitt, L; Dominick, KR; Pedapati, EV; Erickson, CA.
Journal of Autism and Developmental Disorders.
2021;
51:1392-1399.